Vanta Bioscience Limited

BSE:540729 Stock Report

Market Cap: ₹130.0m

Vanta Bioscience Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Dopesh Mulakala

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure9.9yrs
CEO ownership13.6%
Management average tenure4.3yrs
Board average tenure8.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Dopesh Mulakala's remuneration changed compared to Vanta Bioscience's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

-₹45m

Jun 30 2025n/an/a

-₹46m

Mar 31 2025n/an/a

-₹48m

Dec 31 2024n/an/a

-₹43m

Sep 30 2024n/an/a

-₹38m

Jun 30 2024n/an/a

-₹31m

Mar 31 2024n/an/a

-₹23m

Dec 31 2023n/an/a

-₹34m

Sep 30 2023n/an/a

-₹45m

Jun 30 2023n/an/a

-₹55m

Mar 31 2023₹250kn/a

-₹65m

Dec 31 2022n/an/a

-₹45m

Sep 30 2022n/an/a

-₹25m

Jun 30 2022n/an/a

-₹12m

Mar 31 2022₹3mn/a

₹882k

Dec 31 2021n/an/a

₹2m

Sep 30 2021n/an/a

₹4m

Jun 30 2021n/an/a

₹4m

Mar 31 2021₹3mn/a

₹4m

Dec 31 2020n/an/a

₹5m

Sep 30 2020n/an/a

₹5m

Jun 30 2020n/an/a

₹8m

Mar 31 2020₹3mn/a

₹10m

Dec 31 2019n/an/a

₹10m

Sep 30 2019n/an/a

₹9m

Jun 30 2019n/an/a

₹8m

Mar 31 2019₹3m₹3m

₹7m

Compensation vs Market: Insufficient data to establish whether Dopesh's total compensation is reasonable compared to companies of similar size in the Indian market.

Compensation vs Earnings: Dopesh's compensation has been consistent with company performance over the past year.

CEO

Dopesh Mulakala (40 yo)

9.9yrs
Tenure

Mr. Dopesh Raja Mulakala has been Managing Director of Vanta Bioscience Limited since April 18, 2017 and its Director since April 29, 2016. He served as Interim Compliance Officer at Vanta Bioscience Limit...

Leadership Team

NamePositionTenureCompensationOwnership
Dopesh Mulakala
MD & Directorno datano data13.59%
₹ 17.7m
Venkata Sathya Dokka
Chief Financial Officer4.3yrs₹1.05mno data
Mangesh Joshi
Vice President of HR & Admin8.8yrsno datano data
Pooja Kothari
Company Secretary & Compliance Officerless than a yearno datano data
Rajarajeswari Balaji
Head of QAUno datano datano data
Vadlamani Girish Shrma
Senior Vice President & TFMno datano datano data
4.3yrs
Average Tenure
52yo
Average Age

Experienced Management: 540729's management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Dopesh Mulakala
MD & Director9.9yrsno data13.59%
₹ 17.7m
Kartini Binti Abdul Manaf
Independent Non-Executive Director2.8yrsno datano data
Padmanabhuni Appaji
Independent Director8.8yrsno datano data
Kathyayani Gonuguntla
Independent Director8.8yrsno datano data
Yogeswara Danda
Independent Director6.8yrsno datano data
8.8yrs
Average Tenure
70yo
Average Age

Experienced Board: 540729's board of directors are considered experienced (8.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/10 15:54
End of Day Share Price 2026/03/04 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vanta Bioscience Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.